Bristol Myers Squibb
Some of the key events about Bristol Myers Squibb
- 1887The company was founded as a drug manufacturing firm in Brooklyn, New York
- 1943Developed one of the world's first mass-produced penicillin for commercial use
- 1954Introduced the first oral penicillin, Penicillin V
- 1967Launched the first synthetic antibiotic, Cephalexin
- 1989Introduced Capoten, the first angiotensin-converting enzyme (ACE) inhibitor for treating hypertension
- 1989Faced allegations of fraudulently marketing the anti-anxiety drug Buspar
- 1991Developed Taxol, a groundbreaking cancer treatment derived from Pacific yew tree bark
- 1994Accused of inflating prices of cancer and AIDS drugs
- 2001Paid $670 million to settle lawsuits over contaminated blood products
- 2002Launched Plavix, a widely used antiplatelet medication
- 2003Charged with conspiracy to commit securities fraud
- 2007Pleaded guilty to making false statements to the FDA about Plavix
- 2010Paid $158 million to settle allegations of Medicaid fraud in Texas
- 2011Received FDA approval for Yervoy, the first immunotherapy for advanced melanoma
- 2012Agreed to pay $80 million for bribing doctors in China
- 2014Introduced Opdivo, an innovative immunotherapy drug for cancer treatment
- 2015Faced criticism for dramatically increasing the price of a cancer drug
- 2016Accused of withholding data about a failed drug trial
- 2019Acquired Celgene Corporation, significantly expanding its oncology and hematology portfolio
- 2019Paid $75 million to resolve Foreign Corrupt Practices Act charges
Disclaimer: This material is written based on information taken from open sources, including Wikipedia, news media, podcasts, and other public sources.
Bristol Myers Squibb Latest news
Bristol Myers Squibb Wins Dismissal of $6.4 Billion Lawsuit Over Drug Approvals
U.S. Medicare Drug Prices Remain High Despite Negotiations
U.S. Appeals Court Limits Scope of Federal Wage Law Class Actions
U.S. Slashes Medicare Drug Prices: Januvia Sees 79% Cut in Historic Move
Global Pharma Giants Eye Chinese Market Despite Geopolitical Tensions
Popular
British markets react to Labour's first budget while Starmer hints at bigger changes
Deadly roof collapse at Serbian train station leaves authorities searching for answers
Pentagon sends powerful military package to Middle East - what's inside?
Intelligence officials expose foreign plot behind fake election video
Famous faces join key politicians for upcoming multi-state campaign tour
Bristol Myers Squibb Wins Dismissal of $6.4 Billion Lawsuit Over Drug Approvals
A federal judge dismissed a $6. 4 billion lawsuit against Bristol Myers Squibb related to delayed drug approvals following its Celgene acquisition. The case was rejected due to improper appointment of the trustee representing shareholders.
U.S. Medicare Drug Prices Remain High Despite Negotiations
Medicare's first negotiated drug prices still exceed those in other high-income nations. The initiative aims to balance affordability and innovation, with significant savings expected from 2026 onwards.
U.S. Appeals Court Limits Scope of Federal Wage Law Class Actions
A divided 7th Circuit Court ruling restricts FLSA collective actions to states where plaintiffs worked, deepening a split among appellate courts. The decision cites a 2017 Supreme Court case, impacting nationwide wage lawsuits.
U.S. Slashes Medicare Drug Prices: Januvia Sees 79% Cut in Historic Move
U. S. announces final prices for first-ever Medicare drug negotiation, affecting 10 costly medications. Merck's Januvia faces steepest cut at 79%, impacting 66 million beneficiaries.
Global Pharma Giants Eye Chinese Market Despite Geopolitical Tensions
Major pharmaceutical companies are actively seeking acquisitions in China, despite Sino-U. S. tensions. This trend highlights the strategic importance of the Chinese market for global drugmakers.